The first glycine‐to‐tryptophan substitution in the COL1A1 gene identified in a patient with progressively‐deforming Osteogenesis imperfecta.

Bibliographic Details
Title: The first glycine‐to‐tryptophan substitution in the COL1A1 gene identified in a patient with progressively‐deforming Osteogenesis imperfecta.
Authors: Sałacińska, Kinga, Michałus, Izabela, Pinkier, Iwona, Rutkowska, Lena, Chlebna‐Sokół, Danuta, Jakubowska‐Pietkiewicz, Elżbieta, Kępczyński, Łukasz, Salachna, Dominik, Gach, Agnieszka
Source: Molecular Genetics & Genomic Medicine; Aug2022, Vol. 10 Issue 8, p1-6, 6p
Subject Terms: OSTEOGENESIS imperfecta, CONNECTIVE tissues, GENETIC disorders, GENES, RARE diseases
Abstract: Background: Osteogenesis imperfecta (OI) is a genetic disorder of connective tissue with variable phenotype and heterogeneous genetic background. Majority of reported mutations are glycine substitutions, whose clinical outcome ranges from mild to perinatal lethal. The phenotype appears to be influenced by the properties of amino acid side chain and the degree of structural aberration of collagen molecules. Since the genotype–phenotype correlation remains unclear, the severity of mutation is mostly predicted according to previously‐reported cases. Although the number of OI variants is constantly expanding, no glycine‐to‐tryptophan substitutions have been reported in COL1A1 gene. Methods: A sample from a 15‐year‐old girl presenting with progressively‐deforming OI type III was tested using an NGS custom gene panel. Multiple bioinformatic and interpretation tools, including mutation databases and conservation analysis, were used for variant classification. The presence of the mutation was verified by Sanger sequencing. Results: A novel heterozygous mutation c.733G>T was identified in the COL1A1 gene (p.Gly245Trp). Conclusions: The discovery of this novel glycine‐to‐tryptophan substitution located in the COL1A1 gene broadens the spectrum of mutations underlying this rare disease and provides useful information on the clinical outcome of such substitutions. [ABSTRACT FROM AUTHOR]
Copyright of Molecular Genetics & Genomic Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:23249269
DOI:10.1002/mgg3.1996
Published in:Molecular Genetics & Genomic Medicine
Language:English